That's the "GIST" of it: Use of adjuvant imatinib after resection of a primary GI stromal tumor Journal Article


Authors: Tap, W. D.; Schwartz, G. K.
Article Title: That's the "GIST" of it: Use of adjuvant imatinib after resection of a primary GI stromal tumor
Keywords: immunohistochemistry; treatment outcome; middle aged; genetics; mutation; case report; patient selection; antineoplastic agents; chemotherapy, adjuvant; cancer staging; positron emission tomography; antineoplastic agent; neoplasm staging; gastrointestinal stromal tumor; imatinib; platelet derived growth factor alpha receptor; stem cell factor receptor; gastrointestinal stromal tumors; proto-oncogene proteins c-kit; receptor, platelet-derived growth factor alpha; computer assisted tomography; protein kinase inhibitor; tumor markers, biological; risk factors; tomography, x-ray computed; pathology; pyrimidines; tumor marker; risk factor; biopsy; protein kinase inhibitors; chemistry; adjuvant chemotherapy; positron-emission tomography; predictive value of tests; gastrectomy; piperazines; piperazine derivative; pyrimidine derivative; stomach neoplasms; b raf kinase; predictive value; proto-oncogene proteins b-raf; braf protein, human; stomach tumor; personalized medicine; benzamide derivative; benzamides; mitosis index; mitotic index; individualized medicine; multimodal imaging; humans; human; male; article
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Start Page: 1543
End Page: 1546
Language: English
DOI: 10.1200/jco.2013.53.5971
PUBMED: 24638004
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 1 August 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gary Schwartz
    385 Schwartz
  2. William Douglas Tap
    372 Tap